TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Sep 11, 2026 · Director Meckler Jeffrey A sold 20K shares at $67.31/share ($1.3M); exercised options for 40K shares

Director Meckler Jeffrey A sold 20K shares at $67.31/share ($1.3M); exercised options for 40K shares

xslF345X06/form4-09112026_040911.xml

xslF345X06/form4-09112026_040911.xmlSEC.gov

Graphics and non-inline formats (not embedded below).